tetranor-PGEM-d6 (CAS 1240398-16-6)
QUICK LINKS
Contains six deuterium atoms at the 13, 13′, 14, 14′, 15, and 15′ positions and is intended for use as an internal standard for the quantification of tetranor PGEM by GC- or LC-mass spectrometry. Tetranor PGEM-d6 is the major urinary metabolite of PGE1 and PGE2 and is used as a urinary marker of PGE2 biosynthesis, and to monitor metabolism after infusion or injection of PGE1 as a pharmaceutical.1,2 Normal healthy males excrete 16-30 µg of tetranor PGEM over a 24-hour period. Females excrete less by about a factor of three. Following oral administration (4 x 50 mg/24 hours) of the COX inhibitor, indomethacin, urinary levels of tetranor PGEM decrease by 75-98% indicating the almost complete loss of PGE2 biosynthesis.1
tetranor-PGEM-d6 (CAS 1240398-16-6) References
1 Hamberg, M. Inhibition of prostaglandin synthesis in man. Biochem Biophys Res Commun 49 720-726 (1972). 2 Honda, H., Fukawa, K., Sawabe, T. Influence of adjuvant arthritis on main urinary metabolites of prostaglandin F and E rats. Prostaglandins 19 259-269 (1980).Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
tetranor-PGEM-d6, 25 µg | sc-224306 | 25 µg | $440.00 | |||
tetranor-PGEM-d6, 50 µg | sc-224306A | 50 µg | $835.00 |